DCF — NORTHEASTERN HEALTH SYSTEM
Enterprise Value: $-205.8M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-205.8M
Enterprise Value
$-65.4M
PV of Cash Flows
$-140.3M
PV of Terminal Value
$-226.0M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $138.7M | $-12.6M | -9.0% | $-18.5M | $-16.8M |
| Year 2 | $142.8M | $-11.6M | -8.0% | $-17.6M | $-14.6M |
| Year 3 | $147.1M | $-10.5M | -7.0% | $-16.7M | $-12.5M |
| Year 4 | $151.5M | $-10.0M | -7.0% | $-16.4M | $-11.2M |
| Year 5 | $156.1M | $-9.9M | -6.0% | $-16.5M | $-10.3M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-205.8M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$134.6M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.09613698345696636
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5